BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35967424)

  • 1. Immunosuppressive landscape in hepatocellular carcinoma revealed by single-cell sequencing.
    Bai Y; Chen D; Cheng C; Li Z; Chi H; Zhang Y; Zhang X; Tang S; Zhao Q; Ang B; Zhang Y
    Front Immunol; 2022; 13():950536. PubMed ID: 35967424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma.
    Lim CJ; Lee YH; Pan L; Lai L; Chua C; Wasser M; Lim TKH; Yeong J; Toh HC; Lee SY; Chan CY; Goh BK; Chung A; Heikenwälder M; Ng IO; Chow P; Albani S; Chew V
    Gut; 2019 May; 68(5):916-927. PubMed ID: 29970455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell data revealed exhaustion of characteristic NK cell subpopulations and T cell subpopulations in hepatocellular carcinoma.
    Cui Z; Li H; Liu C; Wang J; Chen C; Hu S; Zhao X; Li G
    Aging (Albany NY); 2024 Apr; 16(7):6550-6565. PubMed ID: 38604154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma.
    Wang Z; He L; Li W; Xu C; Zhang J; Wang D; Dou K; Zhuang R; Jin B; Zhang W; Hao Q; Zhang K; Zhang W; Wang S; Gao Y; Gu J; Shang L; Tan Z; Su H; Zhang Y; Zhang C; Li M
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34489334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Analysis of the Immunosuppressive Function of Regulatory T Cells in Human Hepatocellular Carcinoma Tissues.
    Ge J; Chen J; Shen Q; Zheng X; Chen X; Shi L; Chen L; Xu B
    Cancer Control; 2024; 31():10732748241251580. PubMed ID: 38712609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell RNA sequencing highlights the role of PVR/PVRL2 in the immunosuppressive tumour microenvironment in hepatocellular carcinoma.
    Li A; Ji B; Yang Y; Ye B; Zhu Q; Hu X; Liu Y; Zhou P; Liu J; Gao R; Zhou Q; Kang B; Jiang Y
    Front Immunol; 2023; 14():1164448. PubMed ID: 37383234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell RNA-sequencing atlas reveals an FABP1-dependent immunosuppressive environment in hepatocellular carcinoma.
    Tang W; Sun G; Ji GW; Feng T; Zhang Q; Cao H; Wu W; Zhang X; Liu C; Liu H; Huang T; Liu L; Xia Y; Wang X
    J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38007237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma.
    Ho DW; Tsui YM; Chan LK; Sze KM; Zhang X; Cheu JW; Chiu YT; Lee JM; Chan AC; Cheung ET; Yau DT; Chia NH; Lo IL; Sham PC; Cheung TT; Wong CC; Ng IO
    Nat Commun; 2021 Jun; 12(1):3684. PubMed ID: 34140495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma.
    Barsch M; Salié H; Schlaak AE; Zhang Z; Hess M; Mayer LS; Tauber C; Otto-Mora P; Ohtani T; Nilsson T; Wischer L; Winkler F; Manne S; Rech A; Schmitt-Graeff A; Bronsert P; Hofmann M; Neumann-Haefelin C; Boettler T; Fichtner-Feigl S; van Boemmel F; Berg T; Rimassa L; Di Tommaso L; Saeed A; D'Alessio A; Pinato DJ; Bettinger D; Binder H; John Wherry E; Schultheiss M; Thimme R; Bengsch B
    J Hepatol; 2022 Aug; 77(2):397-409. PubMed ID: 35367533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating bulk and single-cell RNA sequencing reveals cellular heterogeneity and immune infiltration in hepatocellular carcinoma.
    Wang T; Dang N; Tang G; Li Z; Li X; Shi B; Xu Z; Li L; Yang X; Xu C; Ye K
    Mol Oncol; 2022 Jun; 16(11):2195-2213. PubMed ID: 35124891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma.
    Shen X; Li N; Li H; Zhang T; Wang F; Li Q
    J Cancer Res Clin Oncol; 2010 Nov; 136(11):1745-54. PubMed ID: 20221638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Analysis of HHLA2 as a Prognostic Biomarker and Its Association With Immune Infiltrates in Hepatocellular Carcinoma.
    Ding L; Yu Q; Yang S; Yang WJ; Liu T; Xian JR; Tian TT; Li T; Chen W; Wang BL; Pan BS; Zhou J; Fan J; Yang XR; Guo W
    Front Immunol; 2022; 13():831101. PubMed ID: 35371079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
    Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
    Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-driven immunosuppression by Treg and type-2 conventional dendritic cells in HCC.
    Suthen S; Lim CJ; Nguyen PHD; Dutertre CA; Lai HLH; Wasser M; Chua C; Lim TKH; Leow WQ; Loh TJ; Wan WK; Pang YH; Soon G; Cheow PC; Kam JH; Iyer S; Kow A; Tam WL; Shuen TWH; Toh HC; Dan YY; Bonney GK; Chan CY; Chung A; Goh BKP; Zhai W; Ginhoux F; Chow PKH; Albani S; Chew V
    Hepatology; 2022 Nov; 76(5):1329-1344. PubMed ID: 35184329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Panoramic comparison between NK cells in healthy and cancerous liver through single-cell RNA sequencing.
    Liu H; Zhao R; Qin R; Sun H; Huang Q; Liu L; Tian Z; Nashan B; Sun C; Sun R
    Cancer Biol Med; 2022 Jul; 19(9):1334-51. PubMed ID: 35856557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma.
    Sheng H; Huang Y; Xiao Y; Zhu Z; Shen M; Zhou P; Guo Z; Wang J; Wang H; Dai W; Zhang W; Sun J; Cao C
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Holliday Cross-Recognition Protein
    Luo D; Liao S; Liu Y; Lin Y; Li Y; Liao X
    Pathol Oncol Res; 2022; 28():1610506. PubMed ID: 35783358
    [No Abstract]   [Full Text] [Related]  

  • 19. Higher frequencies of GARP(+)CTLA-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality.
    Kalathil S; Lugade AA; Miller A; Iyer R; Thanavala Y
    Cancer Res; 2013 Apr; 73(8):2435-44. PubMed ID: 23423978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma.
    Sun Y; Wu L; Zhong Y; Zhou K; Hou Y; Wang Z; Zhang Z; Xie J; Wang C; Chen D; Huang Y; Wei X; Shi Y; Zhao Z; Li Y; Guo Z; Yu Q; Xu L; Volpe G; Qiu S; Zhou J; Ward C; Sun H; Yin Y; Xu X; Wang X; Esteban MA; Yang H; Wang J; Dean M; Zhang Y; Liu S; Yang X; Fan J
    Cell; 2021 Jan; 184(2):404-421.e16. PubMed ID: 33357445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.